Both in Pharmaceuticals
Neurogene vs Aclaris Therapeutics
Over the past year NGNE returned −13.6% and ACRS returned +44.7%; their daily moves had a correlation of 0.21.
NGNE −13.6% ACRS +44.7%Growth of $1, one year, split-adjusted
| Metric | NGNE | ACRS |
|---|---|---|
| Price | $26.85 | $3.71 |
| Market cap | $537.3M | $574.2M |
| Today | +0.67% | −0.94% |
| 1 month | +5.5% | +0.1% |
| 6 months | −17.0% | −22.5% |
| Year to date | +30.3% | +23.1% |
| 1 year | −13.6% | +44.7% |
| Revenue growth (YoY) | — | −8.3% |
| Gross margin | — | 86.6% |
| Net margin | — | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 69.9× |
| Net cash | $225.4M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 76.3% | 75.7% |
| Short % of float | 39.6% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).